5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with ganciclovir in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Couderc, BC; Darbon, JM; de Neuville, S; Douin-Echinard, V; Malecaze, F; Manenti, S; Serres, B | 1 |
Castro, MG; Darling, JL; Lowenstein, PR; Maleniak, TC | 1 |
2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and ganciclovir
Article | Year |
---|---|
Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.
Topics: Animals; Antiviral Agents; beta-Galactosidase; Cataract; Cell Count; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Female; Galactosides; Ganciclovir; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Therapy; Herpesvirus 1, Human; Indoles; Lens Capsule, Crystalline; Rabbits; Recombinant Fusion Proteins; Retroviridae; Staining and Labeling; Thymidine Kinase; Transfection | 1999 |
Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
Topics: Adenoviridae; Antineoplastic Agents, Alkylating; Apoptosis; beta-Galactosidase; Brain Neoplasms; Combined Modality Therapy; DNA, Recombinant; Drug Resistance, Neoplasm; Fas Ligand Protein; Galactosides; Ganciclovir; Gene Expression; Genetic Therapy; Genetic Vectors; Glioblastoma; Herpesvirus 1, Human; Humans; Indoles; Lomustine; Membrane Glycoproteins; Thymidine Kinase; Tumor Cells, Cultured | 2001 |